Dudediligence.

Kodiak Sciences Inc

KODNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

62.8M

on 2026-06-30, from 52.5M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

None

No at-the-market programme on file in the last 30 months.

Warrants

The 10-Q filed 2026-08-13 is not read yet.

Cash

3.2 quarters

$125.9M on 2026-06-30 ÷ $39.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-12-17Public offering6,956,522$23.00$160.0M424B5 ↗